These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 31861113)

  • 1. Editorial of Special Issue "Surface-Functionalized Nanoparticles as Drug Carriers".
    Layek B; Singh J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of Nanotechnology in Solving Oral Drug Delivery Challenges: A Perspective Review.
    Dhadde SB; Patil JS; Chandakavathe BN; Thippeswamy BS; Kavatekar MG
    Crit Rev Ther Drug Carrier Syst; 2020; 37(5):407-434. PubMed ID: 33389846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections.
    Gondil VS; Dube T; Panda JJ; Yennamalli RM; Harjai K; Chhibber S
    Int J Pharm; 2020 Jan; 573():118850. PubMed ID: 31759993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Brief Analysis of Peptide-combined Nanoparticle: Nanomedicine's Unique Value.
    Wang J; Wu J; Li Y; Wen J; Cai J; Tang T; Hu X; Xiang D
    Curr Protein Pept Sci; 2020; 21(4):334-343. PubMed ID: 32039679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments of nanoparticle-delivered dosage forms for buccal delivery.
    Tran PHL; Duan W; Tran TTD
    Int J Pharm; 2019 Nov; 571():118697. PubMed ID: 31526839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of nanotechnology-based Chinese herb drugs on biological activities.
    Huang S; Chang WH
    Curr Drug Metab; 2009 Oct; 10(8):905-13. PubMed ID: 20214585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bird's eye view of nanoparticles prepared by electrospraying: advancements in drug delivery field.
    Pawar A; Thakkar S; Misra M
    J Control Release; 2018 Sep; 286():179-200. PubMed ID: 30053427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained-release from nanocarriers: a review.
    Natarajan JV; Nugraha C; Ng XW; Venkatraman S
    J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized gold nanoparticles for drug delivery.
    Han G; Ghosh P; Rotello VM
    Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake.
    Ho DK; Costa A; De Rossi C; de Souza Carvalho-Wodarz C; Loretz B; Lehr CM
    Mol Pharm; 2018 Mar; 15(3):1081-1096. PubMed ID: 29425049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of New Bexarotene-loaded Mesoporous Silica Systems for Topical Pharmaceutical Formulations.
    Vasile A; Ignat M; Zaltariov MF; Sacarescu L; Stoleriu I; Draganescu D; Dumitras M; Ochiuz L
    Acta Chim Slov; 2018 Mar; 65(1):97-107. PubMed ID: 29562115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Zein Conjugation and Surface Modification for Targeting Drug Delivery.
    Tran PH; Tran TT
    Curr Drug Targets; 2020; 21(4):406-415. PubMed ID: 31518220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of porous silicon nanocarriers for parenteral peptide delivery.
    Kovalainen M; Mönkäre J; Kaasalainen M; Riikonen J; Lehto VP; Salonen J; Herzig KH; Järvinen K
    Mol Pharm; 2013 Jan; 10(1):353-9. PubMed ID: 23186283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
    Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.